Chemomab Therapeutics (CMMB) Stock Chart & Stock Price History $3.38 -0.07 (-2.03%) Closing price 04:00 PM EasternExtended Trading$3.37 -0.01 (-0.30%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Chemomab Therapeutics Stock Price Performance The Chemomab Therapeutics (CMMB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 35.50%, with a year-to-date return of -53.31%. In the past month, the stock has increased 19.86%, reflecting recent market activity. As of the latest close, Chemomab Therapeutics traded at $3.45 with a market cap of $17.85 million and volume of 224,578 shares. Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+3.05%1 Month Performance+19.86%3 Month Performance-26.52%Year-To-Date Performance-53.31%1 Year Performance-35.50% CMMB Stock Chart for Wednesday, October, 15, 2025 CMMB Chart by TradingView Chemomab Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/15/2025$3.45$3.38-2.03%$3.50$3.23115,465 shs$17.48 million10/14/2025$3.36$3.45+2.68%$3.47$3.28224,578 shs$17.85 million10/13/2025$3.28$3.36+2.44%$3.45$3.17242,327 shs$17.37 million10/10/2025$3.37$3.28-2.67%$3.49$3.03332,177 shs$16.96 million10/09/2025$3.50$3.37-3.71%$3.55$3.30249,339 shs$17.42 million10/08/2025$3.48$3.50+0.57%$3.50$3.30412,581 shs$18.11 million10/07/2025$2.87$3.48+21.25%$3.58$2.951.46 million shs$17.99 million10/06/2025$2.72$2.87+5.51%$2.90$2.70207,134 shs$14.84 million10/03/2025$2.70$2.72+0.74%$2.79$2.67165,423 shs$14.06 million10/02/2025$2.64$2.70+2.27%$2.70$2.64115,946 shs$13.97 million Get the Latest News and Ratings for CMMB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/01/2025$2.63$2.64+0.38%$2.70$2.6075,217 shs$13.65 million09/30/2025$2.65$2.63-0.75%$2.77$2.60232,109 shs$13.60 million09/29/2025$2.64$2.65+0.38%$2.79$2.60344,978 shs$13.71 million09/26/2025$2.50$2.64+5.60%$2.79$2.49283,205 shs$13.66 million09/25/2025$2.60$2.50-3.85%$2.63$2.41137,329 shs$12.93 million09/24/2025$2.60$2.60$2.75$2.55327,093 shs$13.44 million09/23/2025$2.63$2.60-1.14%$2.70$2.5934,434 shs$13.45 million09/22/2025$2.65$2.63-0.75%$2.67$2.39121,242 shs$13.60 million09/19/2025$2.63$2.65+0.76%$2.69$2.6053,216 shs$13.70 million09/18/2025$2.62$2.63+0.38%$2.75$2.5879,373 shs$13.60 million09/17/2025$2.80$2.62-6.43%$2.78$2.59110,966 shs$13.55 million09/16/2025$2.82$2.80-0.71%$2.99$2.7053,559 shs$14.48 million09/15/2025$3.03$2.82-6.93%$3.03$2.70140,415 shs$14.58 million Related Companies ABVC Stock Chart GANX Stock Chart STRO Stock Chart ARTV Stock Chart DTIL Stock Chart BYSI Stock Chart JATT Stock Chart RLMD Stock Chart TVRD Stock Chart ESLA Stock Chart Receive CMMB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Chemomab Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CMMB) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemomab Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemomab Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
